Value and Utility of Self-Monitoring of Blood Glucose in Non-Insulin-Treated Patients With Type 2 Diabetes Mellitus
- 1 May 2013
- journal article
- research article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 125 (3) , 191-204
Abstract
Self-monitoring of blood glucose (SMBG) levels provides important information regarding glycemic control for patients with diabetes, and is recommended by European and American diabetes organizations as an essential adjunct to periodic glycated hemoglobin (HbA1c) level monitoring. The benefits of SMBG in improving glycemic control in patients with type 1 diabetes and those with type 2 diabetes (T2DM) who are being treated with insulin are well recognized. In contrast, the potential role of SMBG in patients with T2DM not treated with insulin remains controversial, which may lead to underutilization of SMBG in this population. Structured SMBG, introduced as part of a treatment intervention, has been associated with modest but significant improvements in HbA1c levels in patients with T2DM who are not taking insulin as part of their management plan. Patient-obtained readings provide valuable real-time feedback on glucose responses to meals and exercise, and provide the patient with guidance on the day-to-day management of their diabetes. Studies have shown that when patients perform self-monitoring as part of their treatment interventions, support through appropriate educational initiatives is critical to ensure that patients understand the rationale for SMBG. Patients should be trained in correct testing technique and data recording for SMBG, as well as target blood glucose and goal HbA1c levels so that they will know when their SMBG readings are out of range. Technology has a potential role in facilitating SMBG-based interventions by improving patient-physician communication and optimizing glycemic control through the use of remote data uploading, data analysis tools, and, perhaps, even text messaging. This review outlines the benefits of SMBG in the management of patients with T2DM not treated with insulin, and highlights strategies for improving the effectiveness of SMBG-based treatment interventions in this population.Keywords
This publication has 56 references indexed in Scilit:
- Standards of Medical Care in Diabetes—2012Diabetes Care, 2011
- Consensus Report: The Current Role of Self-Monitoring of Blood Glucose in Non-Insulin-Treated Type 2 DiabetesJournal of Diabetes Science and Technology, 2011
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care PlanEndocrine Practice, 2011
- Legacy Effects from DCCT and UKPDS: What They Mean and Implications for Future Diabetes TrialsCurrent Atherosclerosis Reports, 2010
- Self-Monitoring of Blood Glucose as Part of the Integral Care of Type 2 DiabetesDiabetes Care, 2009
- Self-monitoring of blood glucose in type 2 diabetes: An inter-country comparisonDiabetes Research and Clinical Practice, 2008
- Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose ToleranceJAMA, 2003
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993